0 XP   0   0   0

Pfizer Inc










Financial Health of Pfizer




Comparing to competitors in the Drug Manufacturers-General industry




  Industry Rankings  


Richest
#1 / 89

Total Sales
#1 / 89

Making Money
#1 / 89

Working Efficiently
#12 / 89

Pfizer Inc
Buy, Hold or Sell?

Should you buy, hold or sell Pfizer?

I guess you are interested in Pfizer Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Pfizer

Let's start. I'm going to help you getting a better view of Pfizer Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Pfizer Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Pfizer Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Pfizer Inc. The closing price on 2022-08-05 was $49.19 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Pfizer Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Pfizer Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pfizer earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • A Net Profit Margin of 35.7% means that $0.36 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pfizer Inc:

  • The MRQ is 35.7%. The company is making a huge profit. +2
  • The TTM is 28.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ35.7%TTM28.6%+7.1%
TTM28.6%YOY22.7%+5.9%
TTM28.6%5Y26.0%+2.6%
5Y26.0%10Y26.0%0.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ35.7%12.5%+23.2%
TTM28.6%15.3%+13.3%
YOY22.7%12.9%+9.8%
5Y26.0%13.0%+13.0%
10Y26.0%14.8%+11.2%
1.1.2. Return on Assets

Shows how efficient Pfizer is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • 5.1% Return on Assets means that Pfizer generated $0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pfizer Inc:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.1%TTM3.9%+1.1%
TTM3.9%YOY2.0%+2.0%
TTM3.9%5Y2.8%+1.1%
5Y2.8%10Y2.8%0.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%1.8%+3.3%
TTM3.9%2.3%+1.6%
YOY2.0%1.8%+0.2%
5Y2.8%2.0%+0.8%
10Y2.8%2.2%+0.6%
1.1.3. Return on Equity

Shows how efficient Pfizer is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • 11.4% Return on Equity means Pfizer generated $0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pfizer Inc:

  • The MRQ is 11.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.0%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.4%TTM9.0%+2.3%
TTM9.0%YOY4.8%+4.2%
TTM9.0%5Y6.7%+2.3%
5Y6.7%10Y6.7%0.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ11.4%4.4%+7.0%
TTM9.0%4.8%+4.2%
YOY4.8%4.7%+0.1%
5Y6.7%4.4%+2.3%
10Y6.7%4.6%+2.1%

1.2. Operating Efficiency of Pfizer Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pfizer is operating .

  • Measures how much profit Pfizer makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • An Operating Margin of 45.9% means the company generated $0.46  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pfizer Inc:

  • The MRQ is 45.9%. The company is operating very efficient. +2
  • The TTM is 37.9%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ45.9%TTM37.9%+8.0%
TTM37.9%YOY31.0%+6.9%
TTM37.9%5Y30.6%+7.3%
5Y30.6%10Y30.6%0.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ45.9%17.1%+28.8%
TTM37.9%18.0%+19.9%
YOY31.0%17.8%+13.2%
5Y30.6%18.1%+12.5%
10Y30.6%18.1%+12.5%
1.2.2. Operating Ratio

Measures how efficient Pfizer is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pfizer Inc:

  • The MRQ is 0.864. The company is less efficient in keeping operating costs low.
  • The TTM is 1.069. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.864TTM1.069-0.204
TTM1.069YOY1.149-0.081
TTM1.0695Y1.086-0.017
5Y1.08610Y1.0860.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8641.085-0.221
TTM1.0691.067+0.002
YOY1.1490.961+0.188
5Y1.0860.964+0.122
10Y1.0860.871+0.215

1.3. Liquidity of Pfizer Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pfizer is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Current Ratio of 1.42 means the company has $1.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pfizer Inc:

  • The MRQ is 1.423. The company is just able to pay all its short-term debts.
  • The TTM is 1.398. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.423TTM1.398+0.025
TTM1.398YOY1.401-0.002
TTM1.3985Y1.402-0.003
5Y1.40210Y1.4020.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4231.443-0.020
TTM1.3981.398+0.000
YOY1.4011.420-0.019
5Y1.4021.392+0.010
10Y1.4021.381+0.021
1.3.2. Quick Ratio

Measures if Pfizer is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • A Quick Ratio of 1.04 means the company can pay off $1.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pfizer Inc:

  • The MRQ is 1.039. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.023. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.039TTM1.023+0.016
TTM1.023YOY0.849+0.175
TTM1.0235Y0.896+0.128
5Y0.89610Y0.8960.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0390.894+0.145
TTM1.0230.822+0.201
YOY0.8490.788+0.061
5Y0.8960.851+0.045
10Y0.8960.830+0.066

1.4. Solvency of Pfizer Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pfizer assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pfizer to Drug Manufacturers-General industry mean.
  • A Debt to Asset Ratio of 0.55 means that Pfizer assets are financed with 55.2% credit (debt) and the remaining percentage (100% - 55.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pfizer Inc:

  • The MRQ is 0.552. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.563. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.552TTM0.563-0.011
TTM0.563YOY0.594-0.031
TTM0.5635Y0.585-0.022
5Y0.58510Y0.5850.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5520.487+0.065
TTM0.5630.503+0.060
YOY0.5940.540+0.054
5Y0.5850.525+0.060
10Y0.5850.517+0.068
1.4.2. Debt to Equity Ratio

Measures if Pfizer is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • A Debt to Equity ratio of 123.6% means that company has $1.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pfizer Inc:

  • The MRQ is 1.236. The company is able to pay all its debts with equity. +1
  • The TTM is 1.294. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.236TTM1.294-0.057
TTM1.294YOY1.477-0.183
TTM1.2945Y1.427-0.133
5Y1.42710Y1.4270.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2360.952+0.284
TTM1.2941.033+0.261
YOY1.4771.157+0.320
5Y1.4271.140+0.287
10Y1.4271.085+0.342

2. Market Valuation of Pfizer Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pfizer generates.

  • Above 15 is considered overpriced but always compare Pfizer to the Drug Manufacturers-General industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pfizer Inc:

  • The EOD is 27.862. Very good. +2
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD27.862MRQ-+27.862
MRQ-TTM-0.000
TTM-YOY32.403-32.403
TTM-5Y14.401-14.401
5Y14.40110Y14.4010.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD27.86274.978-47.116
MRQ-84.344-84.344
TTM-77.005-77.005
YOY32.40385.751-53.348
5Y14.40177.578-63.177
10Y14.40167.220-52.819

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pfizer is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pfizer Inc:

  • The EOD is 3.155. Neutral. Compare to industry.
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD3.155MRQ-+3.155
MRQ-TTM-0.000
TTM-YOY1.470-1.470
TTM-5Y0.653-0.653
5Y0.65310Y0.6530.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD3.1552.964+0.191
MRQ-3.222-3.222
TTM-3.620-3.620
YOY1.4703.578-2.108
5Y0.6533.172-2.519
10Y0.6533.020-2.367
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pfizer Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8530.764+12%0.256+233%1.732-51%1.732-51%
Book Value Growth--0.0550.053+3%0.020+169%0.037+49%0.037+49%
Book Value Per Share--15.58914.412+8%11.948+30%12.994+20%12.994+20%
Book Value Per Share Growth--0.0550.053+3%0.020+169%0.037+49%0.037+49%
Current Ratio--1.4231.398+2%1.401+2%1.402+2%1.402+2%
Debt To Asset Ratio--0.5520.563-2%0.594-7%0.585-6%0.585-6%
Debt To Equity Ratio--1.2361.294-4%1.477-16%1.427-13%1.427-13%
Dividend Per Share--0.4000.395+1%0.385+4%0.388+3%0.388+3%
Dividend Per Share Growth---0.0020.007-133%0.008-127%0.008-130%0.008-130%
Eps--1.7651.306+35%0.589+200%0.910+94%0.910+94%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.3570.286+25%0.227+57%0.260+37%0.260+37%
Operating Margin--0.4590.379+21%0.310+48%0.306+50%0.306+50%
Operating Ratio--0.8641.069-19%1.149-25%1.086-20%1.086-20%
Pb Ratio3.155+100%--0%1.470-100%0.653-100%0.653-100%
Pe Ratio27.862+100%--0%32.403-100%14.401-100%14.401-100%
Price Per Share49.190+100%--0%17.599-100%7.822-100%7.822-100%
Profit Growth--20.614-7.726+137%-56.340+373%-32.033+255%-32.033+255%
Quick Ratio--1.0391.023+2%0.849+22%0.896+16%0.896+16%
Return On Assets--0.0510.039+29%0.020+155%0.028+78%0.028+78%
Return On Equity--0.1140.090+26%0.048+135%0.067+68%0.067+68%
Revenue Growth--0.0750.087-14%-0.047+163%0.020+278%0.020+278%
Total Gains Per Share--1.2531.159+8%0.641+95%2.121-41%2.121-41%
Total Gains Per Share Growth---0.081-0.054-33%-10.075+12335%-5.064+6151%-5.064+6151%
Usd Book Value--87469000000.00080895750000.000+8%67037000000.000+30%72921666666.667+20%72921666666.667+20%
Usd Book Value Change Per Share--0.8530.764+12%0.256+233%1.732-51%1.732-51%
Usd Book Value Per Share--15.58914.412+8%11.948+30%12.994+20%12.994+20%
Usd Dividend Per Share--0.4000.395+1%0.385+4%0.388+3%0.388+3%
Usd Eps--1.7651.306+35%0.589+200%0.910+94%0.910+94%
Usd Price Per Share49.190+100%--0%17.599-100%7.822-100%7.822-100%
Usd Profit--9906000000.0007327250000.000+35%3307000000.000+200%5107000000.000+94%5107000000.000+94%
Usd Revenue--27742000000.00025333750000.000+10%12909250000.000+115%18308111111.111+52%18308111111.111+52%
Usd Total Gains Per Share--1.2531.159+8%0.641+95%2.121-41%2.121-41%
 EOD+1 -3MRQTTM+25 -3YOY+30 -25Y+26 -610Y+26 -6

3.2. Fundamental Score

Let's check the fundamental score of Pfizer Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.862
Price to Book Ratio (EOD)Between0-13.155
Net Profit Margin (MRQ)Greater than00.357
Operating Margin (MRQ)Greater than00.459
Quick Ratio (MRQ)Greater than11.039
Current Ratio (MRQ)Greater than11.423
Debt to Asset Ratio (MRQ)Less than10.552
Debt to Equity Ratio (MRQ)Less than11.236
Return on Equity (MRQ)Greater than0.150.114
Return on Assets (MRQ)Greater than0.050.051
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Pfizer Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.355
Ma 20Greater thanMa 5051.262
Ma 50Greater thanMa 10046.168
Ma 100Greater thanMa 20041.067
OpenGreater thanClose49.440
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets195,290,000
Total Liabilities107,821,000
Total Stockholder Equity87,208,000
 As reported
Total Liabilities 107,821,000
Total Stockholder Equity+ 87,208,000
Total Assets = 195,290,000

Assets

Total Assets195,290,000
Total Current Assets67,466,000
Long-term Assets67,466,000
Total Current Assets
Cash And Cash Equivalents 1,780,000
Short-term Investments 31,524,000
Net Receivables 17,738,000
Inventory 10,454,000
Other Current Assets 5,962,000
Total Current Assets  (as reported)67,466,000
Total Current Assets  (calculated)67,458,000
+/- 8,000
Long-term Assets
Property Plant Equipment 15,244,000
Goodwill 49,891,000
Long Term Investments 18,963,000
Intangible Assets 29,065,000
Other Assets 14,662,000
Long-term Assets  (as reported)127,824,000
Long-term Assets  (calculated)127,825,000
+/- 1,000

Liabilities & Shareholders' Equity

Total Current Liabilities47,410,000
Long-term Liabilities60,411,000
Total Stockholder Equity87,208,000
Total Current Liabilities
Short Long Term Debt 5,990,000
Accounts payable 6,208,000
Other Current Liabilities 28,882,000
Total Current Liabilities  (as reported)47,410,000
Total Current Liabilities  (calculated)41,080,000
+/- 6,330,000
Long-term Liabilities
Long term Debt 34,294,000
Other Liabilities 25,911,000
Long-term Liabilities Other 11,312,000
Long-term Liabilities  (as reported)60,411,000
Long-term Liabilities  (calculated)71,517,000
+/- 11,106,000
Total Stockholder Equity
Common Stock476,000
Retained Earnings 116,608,000
Other Stockholders Equity -7,120,000
Total Stockholder Equity (as reported)87,208,000
Total Stockholder Equity (calculated)109,964,000
+/- 22,756,000
Other
Capital Stock476,000
Common Stock Shares Outstanding 5,593,000
Net Debt 38,504,000
Net Invested Capital 127,492,000
Net Tangible Assets 8,252,000
Net Working Capital 20,056,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
> Total Assets 
177,934,000
178,983,000
154,229,000
158,818,000
169,920,000
179,188,000
181,476,000
183,841,000
195,290,000
195,290,000183,841,000181,476,000179,188,000169,920,000158,818,000154,229,000178,983,000177,934,000
   > Total Current Assets 
46,424,000
47,739,000
35,067,000
39,533,000
48,814,000
57,900,000
59,693,000
54,420,000
67,466,000
67,466,00054,420,00059,693,00057,900,00048,814,00039,533,00035,067,00047,739,00046,424,000
       Cash And Cash Equivalents 
1,801,000
1,587,000
1,784,000
1,768,000
2,372,000
1,966,000
1,944,000
2,470,000
1,780,000
1,780,0002,470,0001,944,0001,966,0002,372,0001,768,0001,784,0001,587,0001,801,000
       Short-term Investments 
9,581,000
8,912,000
10,437,000
11,899,000
19,328,000
27,730,000
29,125,000
21,427,000
31,524,000
31,524,00021,427,00029,125,00027,730,00019,328,00011,899,00010,437,0008,912,0009,581,000
       Net Receivables 
9,128,000
14,012,000
11,194,000
13,283,000
14,348,000
15,774,000
15,745,000
16,342,000
17,738,000
17,738,00016,342,00015,745,00015,774,00014,348,00013,283,00011,194,00014,012,0009,128,000
       Inventory 
8,564,000
9,295,000
8,046,000
8,493,000
8,948,000
8,640,000
9,059,000
9,979,000
10,454,000
10,454,0009,979,0009,059,0008,640,0008,948,0008,493,0008,046,0009,295,0008,564,000
       Other Current Assets 
2,512,000
13,917,000
3,588,000
4,085,000
3,816,000
3,784,000
3,816,000
4,197,000
5,962,000
5,962,0004,197,0003,816,0003,784,0003,816,0004,085,0003,588,00013,917,0002,512,000
   > Long-term Assets 
131,511,000
131,245,000
119,163,000
119,284,000
121,106,000
121,288,000
121,782,000
129,420,000
127,824,000
127,824,000129,420,000121,782,000121,288,000121,106,000119,284,000119,163,000131,245,000131,511,000
       Property Plant Equipment 
0
14,403,000
15,293,000
14,011,000
14,224,000
14,436,000
17,721,000
15,109,000
15,244,000
15,244,00015,109,00017,721,00014,436,00014,224,00014,011,00015,293,00014,403,0000
       Goodwill 
58,449,000
59,902,000
49,577,000
49,791,000
49,867,000
49,489,000
49,208,000
50,211,000
49,891,000
49,891,00050,211,00049,208,00049,489,00049,867,00049,791,00049,577,00059,902,00058,449,000
       Long Term Investments 
18,720,000
19,008,000
20,262,000
20,228,000
20,942,000
21,597,000
21,526,000
20,737,000
18,963,000
18,963,00020,737,00021,526,00021,597,00020,942,00020,228,00020,262,00019,008,00018,720,000
       Intangible Assets 
33,542,000
30,928,000
28,472,000
27,973,000
27,323,000
26,306,000
25,146,000
29,816,000
29,065,000
29,065,00029,816,00025,146,00026,306,00027,323,00027,973,00028,472,00030,928,00033,542,000
       Long-term Assets Other 
4,327,000
4,355,000
4,569,000
4,744,000
6,056,000
6,705,000
7,679,000
7,879,000
7,659,000
7,659,0007,879,0007,679,0006,705,0006,056,0004,744,0004,569,0004,355,0004,327,000
> Total Liabilities 
113,370,000
113,488,000
90,756,000
89,953,000
99,605,000
103,221,000
104,014,000
101,156,000
107,821,000
107,821,000101,156,000104,014,000103,221,00099,605,00089,953,00090,756,000113,488,000113,370,000
   > Total Current Liabilities 
32,723,000
34,154,000
25,920,000
26,652,000
35,664,000
41,803,000
42,671,000
39,268,000
47,410,000
47,410,00039,268,00042,671,00041,803,00035,664,00026,652,00025,920,00034,154,00032,723,000
       Short Long Term Debt 
13,083,000
13,364,000
2,703,000
4,352,000
3,888,000
3,629,000
2,241,000
636,000
5,990,000
5,990,000636,0002,241,0003,629,0003,888,0004,352,0002,703,00013,364,00013,083,000
       Accounts payable 
3,872,000
4,141,000
4,309,000
4,064,000
4,327,000
4,698,000
5,578,000
5,506,000
6,208,000
6,208,0005,506,0005,578,0004,698,0004,327,0004,064,0004,309,0004,141,0003,872,000
       Other Current Liabilities 
10,170,000
10,382,000
12,076,000
12,591,000
21,690,000
26,965,000
26,732,000
26,570,000
28,882,000
28,882,00026,570,00026,732,00026,965,00021,690,00012,591,00012,076,00010,382,00010,170,000
   > Long-term Liabilities 
80,647,000
79,334,000
64,836,000
63,301,000
63,941,000
61,418,000
61,343,000
61,888,000
60,411,000
60,411,00061,888,00061,343,00061,418,00063,941,00063,301,00064,836,00079,334,00080,647,000
       Long term Debt 
50,529,000
48,164,000
35,571,000
33,836,000
33,847,000
34,779,000
34,757,000
34,416,000
34,294,000
34,294,00034,416,00034,757,00034,779,00033,847,00033,836,00035,571,00048,164,00050,529,000
       Other Liabilities 
0
29,549,000
26,589,000
27,954,000
28,587,000
25,169,000
22,637,000
26,092,000
25,911,000
25,911,00026,092,00022,637,00025,169,00028,587,00027,954,00026,589,00029,549,0000
       Long-term Liabilities Other 
6,811,000
6,850,000
6,669,000
6,678,000
8,228,000
9,202,000
9,744,000
10,509,000
11,312,000
11,312,00010,509,0009,744,0009,202,0008,228,0006,678,0006,669,0006,850,0006,811,000
> Total Stockholder Equity
64,336,000
65,259,000
63,238,000
68,620,000
70,042,000
75,691,000
77,201,000
82,424,000
87,208,000
87,208,00082,424,00077,201,00075,691,00070,042,00068,620,00063,238,00065,259,00064,336,000
   Common Stock
0
470,000
470,000
472,000
472,000
473,000
473,000
476,000
476,000
476,000476,000473,000473,000472,000472,000470,000470,0000
   Retained Earnings 
100,203,000
100,284,000
96,770,000
95,158,000
96,346,000
102,252,000
103,394,000
111,193,000
116,608,000
116,608,000111,193,000103,394,000102,252,00096,346,00095,158,00096,770,000100,284,000100,203,000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity -7,120,000-6,158,000-5,896,000-5,648,000-4,756,000-4,663,000-11,688,000-12,676,0000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue81,288,000
Cost of Revenue-30,821,000
Gross Profit50,467,00050,467,000
 
Operating Income (+$)
Gross Profit50,467,000
Operating Expense-61,053,000
Operating Income20,235,000-10,586,000
 
Operating Expense (+$)
Research Development13,829,000
Selling General Administrative12,703,000
Selling And Marketing Expenses-
Operating Expense61,053,00026,532,000
 
Net Interest Income (+$)
Interest Income36,000
Interest Expense-1,291,000
Net Interest Income-1,255,000-1,255,000
 
Pretax Income (+$)
Operating Income20,235,000
Net Interest Income-1,255,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)24,311,00014,904,000
EBIT - interestExpense = 25,554,000
23,831,000
23,270,000
Interest Expense1,291,000
Earnings Before Interest and Taxes (ebit)26,845,00025,602,000
Earnings Before Interest and Taxes (ebitda)29,302,000
 
After tax Income (+$)
Income Before Tax24,311,000
Tax Provision-1,852,000
Net Income From Continuing Ops22,459,00022,459,000
Net Income21,979,000
Net Income Applicable To Common Shares21,979,000
 
Non-recurring Events
Discontinued Operations-434,000
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net5,331,0001,255,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
OILNF.PINK
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of OILNF.PINK.

OILNF.PINK Daily Candlestick Chart
EGHT.NYSE
7 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of EGHT.NYSE.

EGHT.NYSE Daily Candlestick Chart
OZ.NYSE
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OZ.NYSE.

OZ.NYSE Daily Candlestick Chart
KTRA.NASDAQ
12 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of KTRA.NASDAQ.

KTRA.NASDAQ Daily Candlestick Chart
GNRS.OTCMKTS
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GNRS.OTCMKTS.

GNRS.OTCMKTS Daily Candlestick Chart
NSTC.NYSE
28 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NSTC.NYSE.

NSTC.NYSE Daily Candlestick Chart
MDH.NYSE
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDH.NYSE.

MDH.NYSE Daily Candlestick Chart
BMTM.OTCQB
34 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BMTM.OTCQB.

BMTM.OTCQB Daily Candlestick Chart
BMTM.PINK
34 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BMTM.PINK.

BMTM.PINK Daily Candlestick Chart
MCAG.NASDAQ
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MCAG.NASDAQ.

MCAG.NASDAQ Daily Candlestick Chart
SGLD.TO
48 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of SGLD.TO.

SGLD.TO Daily Candlestick Chart
OR.TO
51 minutes ago

I found you a Golden Cross on the daily chart of OR.TO.

OR.TO Daily Candlestick Chart
MAG.TO
56 minutes ago

I found you a Golden Cross on the daily chart of MAG.TO.

MAG.TO Daily Candlestick Chart
L.TO
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of L.TO.

L.TO Daily Candlestick Chart
HUT.TO
59 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of HUT.TO.

HUT.TO Daily Candlestick Chart
GTMS.TO
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of GTMS.TO.

GTMS.TO Daily Candlestick Chart
PNPN.V
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
YFI.V
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of YFI.V.

YFI.V Daily Candlestick Chart
NCP.TO
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of NCP.TO.

NCP.TO Daily Candlestick Chart
XDU.TO
1 hour ago

I found you a Golden Cross on the daily chart of XDU.TO.

XDU.TO Daily Candlestick Chart
MXG.TO
1 hour ago

I found you a Death Cross on the daily chart of MXG.TO.

MXG.TO Daily Candlestick Chart
ZDM.TO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZDM.TO.

ZDM.TO Daily Candlestick Chart
TIXT.TO
1 hour ago

I found you a Death Cross on the daily chart of TIXT.TO.

TIXT.TO Daily Candlestick Chart
ZORDIX-B.ST
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZORDIX-B.ST.

ZORDIX-B.ST Daily Candlestick Chart
RCSL3.SA
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RCSL3.SA.

RCSL3.SA Daily Candlestick Chart